National-Institute-Allergy-Infectious-Disease

Treating peanut allergy with skin patch ( epicutaneous immunotherapy ) shows promising results

A wearable patch that delivers small amounts of peanut protein through the skin shows promise for treating children and young adults with peanut allergy, with greater benefits for younger children, according to one-year results from an ongoing clinical trial. The treatment, called epicutaneous immunotherapy or EPIT, was safe and well-tolerated, and nearly all participants used …

Treating peanut allergy with skin patch ( epicutaneous immunotherapy ) shows promising results Read More »

National Institute of Health scientists find genes causing frustrating syndrome

Scientists at the National Institutes of Health have identified a genetic explanation for a syndrome characterized by multiple frustrating and difficult-to-treat symptoms, including dizziness and lightheadedness, skin flushing and itching, gastrointestinal complaints, chronic pain, and bone and joint problems. Some people who experience these diverse symptoms have elevated levels of tryptase — a protein in …

National Institute of Health scientists find genes causing frustrating syndrome Read More »